Investigating the safety and efficacy of nabilone for the treatment of agitation in patients with moderate-to-severe Alzheimer's disease: Study protocol for a cross-over randomized controlled trial

Agitation is a prevalent and difficult-to-treat symptom in patients with moderate-to-severe Alzheimer's disease (AD). Though there are nonpharmacological and pharmacological interventions recommended for the treatment of agitation, the efficacy of these are modest and not always consistent. Fur...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Contemp Clin Trials Commun
Hauptverfasser: Ruthirakuhan, Myuri T., Herrmann, Nathan, Gallagher, Damien, Andreazza, Ana C., Kiss, Alexander, Verhoeff, Nicolaas Paul L.G., Black, Sandra E., Lanctôt, Krista L.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Elsevier 2019
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6627000/
https://ncbi.nlm.nih.gov/pubmed/31338476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.conctc.2019.100385
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge